Yale Researchers Identify Tumor Reactive Immune-Cells to help fight against Advanced Melanoma
Yale Cancer Center/Smilow Cancer HospitalAccording to a new study led by Yale Cancer Center and Department of Neurology researchers, a simple blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma, a deadly form of skin cancer. The findings were published today in the Journal of Experimental Medicine.